US lawmakers are demanding answers from the Food and Drug Administration about a shortage of infant formula products as demand for production by other firms grows following the closing of an Abbott Nutrition plant due to contamination concerns.
US Lawmakers Want Answers From FDA On Infant Formula Shortage Following Abbott Recall
House Appropriations and Energy and Commerce subcommittees will ask about Abbott Nutrition’s recall of infant formula made at its Sturgis, MI, facility. “We are doing everything in our power to ensure there is adequate product available where and when they need it,” says FDA Commissioner Robert Califf.
